{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:01:45Z","timestamp":1780534905548,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan","award":["BR24992933"],"award-info":[{"award-number":["BR24992933"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48078-1","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:45:00Z","timestamp":1776141900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Germline pathogenic variant spectrum and prevalence among colorectal cancer patients undergoing multigene panel testing in Kazakhstan"],"prefix":"10.1038","volume":"16","author":[{"given":"Nurlan","family":"Baltayev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saltanat","family":"Abdikerim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiy","family":"Afonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsen","family":"Rasulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigul","family":"Zhunussova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilyara","family":"Kaidarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnur","family":"Zhunussova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"48078_CR1","doi-asserted-by":"publisher","unstructured":"Kaidarova, D. R. et al. in Indicators of the Oncology Service of the Republic of Kazakhstan, 2023 (Statistical and Analytical Materials). (eds Kaidarova, D. R.) (KIOR JSC, 2024). https:\/\/doi.org\/10.52532\/20-09-2024-1-410","DOI":"10.52532\/20-09-2024-1-410"},{"key":"48078_CR2","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1200\/JCO.22.02378","volume":"41","author":"HM Seagle","year":"2023","unstructured":"Seagle, H. M., Keller, S. R., Tavtigian, S. V., Horton, C. & Holowatyj, A. N. Clinical multigene panel testing identifies racial and ethnic differences in germline pathogenic variants among patients with early-onset colorectal cancer. J. Clin. Oncol. 41, 4279\u20134289. https:\/\/doi.org\/10.1200\/JCO.22.02378 (2023).","journal-title":"J. Clin. Oncol."},{"key":"48078_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00673","volume":"9","author":"G Zhunussova","year":"2019","unstructured":"Zhunussova, G. et al. Mutation spectrum of cancer-associated genes in patients with early onset of colorectal cancer. Front. Oncol. 9, 673. https:\/\/doi.org\/10.3389\/fonc.2019.00673 (2019).","journal-title":"Front. Oncol."},{"key":"48078_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jamaoncol.2016.5194","volume":"3","author":"R Pearlman","year":"2017","unstructured":"Pearlman, R. et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 3, 464\u2013471. https:\/\/doi.org\/10.1001\/jamaoncol.2016.5194 (2017).","journal-title":"JAMA Oncol."},{"key":"48078_CR5","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","volume":"138","author":"KW Jasperson","year":"2010","unstructured":"Jasperson, K. W., Tuohy, T. M., Neklason, D. W. & Burt, R. W. Hereditary and familial colon cancer. Gastroenterology 138, 2044\u20132058. https:\/\/doi.org\/10.1053\/j.gastro.2010.01.054 (2010).","journal-title":"Gastroenterology"},{"key":"48078_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.cgh.2023.08.028","volume":"22.3","author":"JN Hatton","year":"2023","unstructured":"Hatton, J. N. et al. Spectrum and excess risk of gastrointestinal tumors in Li-Fraumeni syndrome. Clin. Gastroenterol. hepatology: official Clin. Pract. J. Am. Gastroenterological Association. 22.3, 662\u2013665. https:\/\/doi.org\/10.1016\/j.cgh.2023.08.028 (2023).","journal-title":"Clin. Gastroenterol. hepatology: official Clin. Pract. J. Am. Gastroenterological Association"},{"key":"48078_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/ijc.35451","volume":"157","author":"F Pirini","year":"2025","unstructured":"Pirini, F. et al. Comprehensive genetic and epigenetic characterization of Lynch-like syndrome patients. Int. J. Cancer. 157, 788\u2013799. https:\/\/doi.org\/10.1002\/ijc.35451 (2025).","journal-title":"Int. J. Cancer"},{"key":"48078_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100607","volume":"7","author":"L Poliani","year":"2022","unstructured":"Poliani, L. et al. Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center. ESMO Open 7, 100607. https:\/\/doi.org\/10.1016\/j.esmoop.2022.100607 (2022).","journal-title":"ESMO Open"},{"key":"48078_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/gutjnl-2013-306567","volume":"64","author":"AK Win","year":"2015","unstructured":"Win, A. K. et al. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut 64, 101\u2013110. https:\/\/doi.org\/10.1136\/gutjnl-2013-306567 (2015).","journal-title":"Gut"},{"key":"48078_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.566266","volume":"11","author":"M Djursby","year":"2020","unstructured":"Djursby, M. et al. New pathogenic germline variants in very early onset and familial colorectal cancer patients. Front. Genet. 11, 566266. https:\/\/doi.org\/10.3389\/fgene.2020.566266 (2020).","journal-title":"Front. Genet."},{"key":"48078_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.amjsurg.2024.01.022","volume":"232","author":"H Ficarino","year":"2024","unstructured":"Ficarino, H. et al. Deficiencies in germline genetic testing in young-onset colorectal cancer patients. Am. J. Surg. 232, 126\u2013130. https:\/\/doi.org\/10.1016\/j.amjsurg.2024.01.022 (2024).","journal-title":"Am. J. Surg."},{"key":"48078_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4251\/wjgo.v14.i3.654","volume":"14","author":"P Currais","year":"2022","unstructured":"Currais, P., Rosa, I. & Claro, I. Colorectal cancer carcinogenesis: From bench to bedside. World J. Gastrointest. Oncol. 14, 654\u2013663. https:\/\/doi.org\/10.4251\/wjgo.v14.i3.654 (2022).","journal-title":"World J. Gastrointest. Oncol."},{"key":"48078_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cancergen.2016.08.005","volume":"209","author":"TP Leedom","year":"2016","unstructured":"Leedom, T. P. et al. Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers. Cancer Genet. 209, 403\u2013407. https:\/\/doi.org\/10.1016\/j.cancergen.2016.08.005 (2016).","journal-title":"Cancer Genet."},{"key":"48078_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/path.5229","volume":"247","author":"L Valle","year":"2019","unstructured":"Valle, L., Vilar, E., Tavtigian, S. V. & Stoffel, E. M. Genetic predisposition to colorectal cancer: Syndromes, genes, classification of genetic variants and implications for precision medicine. J. Pathol. 247, 574\u2013588. https:\/\/doi.org\/10.1002\/path.5229 (2019).","journal-title":"J. Pathol."},{"key":"48078_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cgh.2022.12.006","volume":"21","author":"GM Cavestro","year":"2023","unstructured":"Cavestro, G. M. et al. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines. Clin. Gastroenterol. Hepatol. 21, 581\u2013603. https:\/\/doi.org\/10.1016\/j.cgh.2022.12.006 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"48078_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/mgg3.317","volume":"5","author":"MS DeRycke","year":"2017","unstructured":"DeRycke, M. S. et al. Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes. Mol. Genet. Genomic Med. 5, 553\u2013569. https:\/\/doi.org\/10.1002\/mgg3.317 (2017).","journal-title":"Mol. Genet. Genomic Med."},{"key":"48078_CR17","first-page":"5571","volume":"11","author":"H Liao","year":"2021","unstructured":"Liao, H. et al. Prevalence and spectrum of germline cancer susceptibility gene variants and somatic second hits in colorectal cancer. Am. J. Cancer Res. 11, 5571\u20135580 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"48078_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmogo.2025.100182","volume":"8","author":"G Mauri","year":"2025","unstructured":"Mauri, G. et al. Germline genomic profiling of patients with early-onset colorectal cancer. ESMO Gastrointestinal Oncology 8, 100182. https:\/\/doi.org\/10.1016\/j.esmogo.2025.100182 (2025).","journal-title":"ESMO Gastrointestinal Oncology"},{"key":"48078_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10689-009-9269-1","volume":"8","author":"B Kaufman","year":"2009","unstructured":"Kaufman, B. et al. Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations. Fam. Cancer 8, 473\u2013478. https:\/\/doi.org\/10.1007\/s10689-009-9269-1 (2009).","journal-title":"Fam. Cancer"},{"issue":"11","key":"48078_CR20","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","volume":"8","author":"BL Bychkovsky","year":"2022","unstructured":"Bychkovsky, B. L. et al. Differences in cancer phenotypes among frequent CHEK2 variants and implications for clinical care-checking CHEK2. JAMA oncology 8(11), 1598\u20131606. https:\/\/doi.org\/10.1001\/jamaoncol.2022.4071 (2022).","journal-title":"JAMA oncology"},{"key":"48078_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/dna.2013.1970","volume":"32","author":"FF Han","year":"2013","unstructured":"Han, F. F., Guo, C. L. & Liu, L. H. The effect of CHEK2 variant I157T on cancer susceptibility: Evidence from a meta-analysis. DNA Cell Biol. 32, 329\u2013335. https:\/\/doi.org\/10.1089\/dna.2013.1970 (2013).","journal-title":"DNA Cell Biol."},{"key":"48078_CR22","first-page":"15708","volume":"8","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Dai, B. & Ye, D. CHEK2 mutation and risk of prostate cancer: A systematic review and meta-analysis. Int. J. Clin. Exp. Med. 8, 15708\u201315715 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"48078_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13053-015-0030-5","volume":"13","author":"M Kaczmarek-Rys\u00b4","year":"2015","unstructured":"Kaczmarek-Rys\u00b4, M. et al. The c.470 T\u2009>\u2009C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population. Hered Cancer Clin. Pract. 13, 8. https:\/\/doi.org\/10.1186\/s13053-015-0030-5 (2015).","journal-title":"Hered Cancer Clin. Pract."},{"key":"48078_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051208","volume":"14","author":"P \u0160vajdler","year":"2022","unstructured":"\u0160vajdler, P. et al. CHEK2p.I157T mutation is associated with increased risk of adult-type ovarian granulosa cell tumors. Cancers (Basel) 14, 1208. https:\/\/doi.org\/10.3390\/cancers14051208 (2022).","journal-title":"Cancers (Basel)"},{"key":"48078_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3062","volume":"13","author":"A Desrichard","year":"2011","unstructured":"Desrichard, A., Bidet, Y., Uhrhammer, N. & Bignon, Y. J. CHEK2 contribution to hereditary breast cancer in non-BRCA families. Breast Cancer Res. 13, R119. https:\/\/doi.org\/10.1186\/bcr3062 (2011).","journal-title":"Breast Cancer Res."},{"key":"48078_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1020543","volume":"13","author":"L Roht","year":"2022","unstructured":"Roht, L. et al. The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: Results from routine clinical setting 2016\u20132021. Front. Genet. 13, 1020543. https:\/\/doi.org\/10.3389\/fgene.2022.1020543 (2022).","journal-title":"Front. Genet."},{"key":"48078_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.20863","volume":"116","author":"E Mangold","year":"2005","unstructured":"Mangold, E. et al. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Int. J. Cancer 116, 692\u2013702. https:\/\/doi.org\/10.1002\/ijc.20863 (2005).","journal-title":"Int. J. Cancer"},{"key":"48078_CR28","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1111\/jcmm.13881","volume":"22","author":"PD Iordache","year":"2018","unstructured":"Iordache, P. D. et al. Identification of Lynch syndrome risk variants in the Romanian population. J. Cell. Mol. Med. 22, 6068\u20136076. https:\/\/doi.org\/10.1111\/jcmm.13881 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"48078_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3343\/lmo.2018.8.4.156","volume":"8","author":"KJ Park","year":"2018","unstructured":"Park, K. J., Chang, D. K., Kim, H. C. & Kim, J. W. Germline variants in MLH1, MSH2, and MSH6 in Korean patients with Lynch Syndrome. Lab. Med. Online 8, 156\u2013166. https:\/\/doi.org\/10.3343\/lmo.2018.8.4.156 (2018).","journal-title":"Lab. Med. Online"},{"key":"48078_CR30","doi-asserted-by":"publisher","unstructured":"Maccaroni, E. et al. Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal?. Oncotarget 36, 38737\u201338748 https:\/\/doi.org\/10.18632\/oncotarget.5395 (2015).","DOI":"10.18632\/oncotarget.5395"},{"key":"48078_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajhg.2018.05.001","volume":"103","author":"BH Shirts","year":"2018","unstructured":"Shirts, B. H. et al. Using somatic mutations from tumors to classify variants in mismatch repair genes. Am. J. Hum. Genet. 103, 19\u201329. https:\/\/doi.org\/10.1016\/j.ajhg.2018.05.001 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"48078_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12863-016-0407-0","volume":"17","author":"B Morris","year":"2016","unstructured":"Morris, B., Hughes, E., Rosenthal, E., Gutin, A. & Bowles, K. R. Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithm. BMC Genet. 17, 99. https:\/\/doi.org\/10.1186\/s12863-016-0407-0 (2016).","journal-title":"BMC Genet."},{"key":"48078_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/ng.2854","volume":"46","author":"BA Thompson","year":"2014","unstructured":"Thompson, B. A. et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat. Genet. 46, 107\u2013115. https:\/\/doi.org\/10.1038\/ng.2854 (2014).","journal-title":"Nat. Genet."},{"key":"48078_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032137","volume":"24","author":"F Rebuzzi","year":"2023","unstructured":"Rebuzzi, F., Ulivi, P. & Tedaldi, G. Genetic predisposition to colorectal cancer: How many and which genes to test?. Int. J. Mol. Sci. 24, 2137. https:\/\/doi.org\/10.3390\/ijms24032137 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"48078_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cancergencyto.2004.07.003","volume":"158","author":"S Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez, S. et al. Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands. Cancer Genet. Cytogenet. 158, 70\u201374. https:\/\/doi.org\/10.1016\/j.cancergencyto.2004.07.003 (2005).","journal-title":"Cancer Genet. Cytogenet."},{"key":"48078_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.gene.2015.11.034","volume":"577","author":"S Zhang","year":"2016","unstructured":"Zhang, S. et al. Novel and reported APC germline mutations in Chinese patients with familial adenomatous polyposis. Gene 577, 187\u2013192. https:\/\/doi.org\/10.1016\/j.gene.2015.11.034 (2016).","journal-title":"Gene"},{"key":"48078_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/jmg.2007.052506","volume":"44","author":"S Aretz","year":"2007","unstructured":"Aretz, S. et al. High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J. Med. Genet. 44, 702\u2013709. https:\/\/doi.org\/10.1136\/jmg.2007.052506 (2007).","journal-title":"J. Med. Genet."},{"key":"48078_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-023-00267-z","volume":"21","author":"K Cao","year":"2023","unstructured":"Cao, K., Plazzer, J. P. & Macrae, F. SMAD4 variants and its genotype-phenotype correlations to juvenile polyposis syndrome. Hered. Cancer Clin. Pract. 21, 27. https:\/\/doi.org\/10.1186\/s13053-023-00267-z (2023).","journal-title":"Hered. Cancer Clin. Pract."},{"key":"48078_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63648","volume":"194","author":"S Vautier","year":"2024","unstructured":"Vautier, S. et al. SMAD4 mosaicism in juvenile polyposis: Essential contribution of somatic analysis in diagnosis. Am. J. Med. Genet. A 194, e63648. https:\/\/doi.org\/10.1002\/ajmg.a.63648 (2024).","journal-title":"Am. J. Med. Genet. A"},{"key":"48078_CR40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.dnarep.2010.03.008","volume":"9","author":"VG D\u2019Agostino","year":"2010","unstructured":"D\u2019Agostino, V. G. et al. Functional analysis of MUTYH mutated proteins associated with familial adenomatous polyposis. DNA Repair. (Amst). 9, 700\u2013707. https:\/\/doi.org\/10.1016\/j.dnarep.2010.03.008 (2010).","journal-title":"DNA Repair. (Amst)"},{"key":"48078_CR41","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/humu.22794","volume":"36","author":"K Komine","year":"2015","unstructured":"Komine, K. et al. Functional complementation assay for 47 MUTYH variants in a MutY-disrupted escherichia coli strain. Hum. Mutat. 36, 704\u2013711. https:\/\/doi.org\/10.1002\/humu.22794 (2015).","journal-title":"Hum. Mutat."},{"key":"48078_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3343\/alm.2024.0242","volume":"45","author":"JE Park","year":"2025","unstructured":"Park, J. E. et al. Carrier frequency and incidence of MUTYH-associated polyposis based on database analysis in East Asians and Koreans. Ann. Lab. Med. 45, 77\u201384. https:\/\/doi.org\/10.3343\/alm.2024.0242 (2025).","journal-title":"Ann. Lab. Med."},{"key":"48078_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.163","author":"S Aretz","year":"2013","unstructured":"Aretz, S., Genuardi, M. & Hes, F. J. Clinical utility gene card for: MUTYH-associated polyposis (MAP), autosomal recessive colorectal adenomatous polyposis, multiple colorectal adenomas, multiple adenomatous polyps (MAP) - Update 2012. Eur. J. Hum. Genet. https:\/\/doi.org\/10.1038\/ejhg.2012.163 (2013).","journal-title":"Eur. J. Hum. Genet."},{"key":"48078_CR44","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1101\/2025.03.01.640912","volume":"112","author":"SL Hemker","year":"2025","unstructured":"Hemker, S. L. et al. Saturation mapping of MUTYH variant effects using DNA repair reporters. bioRxiv 112, 2010\u20132026. https:\/\/doi.org\/10.1101\/2025.03.01.640912 (2025).","journal-title":"bioRxiv"},{"key":"48078_CR45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1053\/j.gastro.2008.10.056","volume":"136","author":"M Nielsen","year":"2009","unstructured":"Nielsen, M. et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology 136, 471\u2013476. https:\/\/doi.org\/10.1053\/j.gastro.2008.10.056 (2009).","journal-title":"Gastroenterology"},{"key":"48078_CR46","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.dld.2023.01.151","volume":"55","author":"G Reznick Levi","year":"2023","unstructured":"Reznick Levi, G. et al. High prevalence of MUTYH associated polyposis among minority populations in Israel, due to rare founder pathogenic variants. Dig. Liver Dis. 55, 880\u2013887. https:\/\/doi.org\/10.1016\/j.dld.2023.01.151 (2023).","journal-title":"Dig. Liver Dis."},{"key":"48078_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.902804","volume":"13","author":"U Kairov","year":"2022","unstructured":"Kairov, U. et al. Whole-genome sequencing and genomic variant analysis of Kazakh individuals. Front. Genet. 13, 902804. https:\/\/doi.org\/10.3389\/fgene.2022.902804 (2022).","journal-title":"Front. Genet."},{"key":"48078_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48078-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48078-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48078-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:10:40Z","timestamp":1780531840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48078-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48078"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48078-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Local Ethics Committee of the Kazakh Research Institute of Oncology and Radiology (Protocol No. 1, May 12, 2021) and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants or from their parents\/legal guardians in the case of minors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17303"}}